Vertex Pharmaceuticals
Luis Maranga, PhD, currently serves as the Senior Vice President of Biopharmaceutical Sciences for Cell and Genetic Therapies at Vertex Pharmaceuticals, leading a team of over 650 in all cell and genetic therapies CMC functions from post-discovery to commercialization. Previously, Luis held significant roles at Sanofi, including SVP & Global Head of MSAT, overseeing a global team of over 400, and contributed as a member of the MIT LGO Governing Board and the SAB of CaraVan Biologix. With extensive experience in biologics development at Bristol-Myers Squibb, Novartis, and other prominent companies, Luis has a strong background in technical operations, manufacturing, and process development. Luis earned a PhD in Chemical Engineering from Universidade Nova de Lisboa and a bachelor's and master's degree in Chemical Engineering from Instituto Superior Técnico.
Vertex Pharmaceuticals
87 followers
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.